India as a Global Medical Tourism Hub

India’s medical tourism market is projected to reach $13 billion by 2026, up from $6 billion in 2022. Foreign tourist arrivals for treatment jumped from 182,945 in 2020 to 644,387 in 2024, with patients paying 60-80% less than OECD rates for procedures including cardiac surgery, orthopaedics, oncology and transplants. Budget 2026-27 has proposed five regional medical hubs integrating healthcare, education, research and AYUSH wellness facilities. For national tourism boards, healthcare companies, insurance groups and economic development agencies, India’s medical tourism growth presents significant partnership and investment opportunities. T&A Consulting helps foreign organisations navigate India’s medical value travel ecosystem and identify strategic entry points.

Introduction: From Cost-Driven Care to Global Healthcare Ecosystem

India’s medical tourism story has evolved significantly from its origins as a low-cost alternative for patients from neighbouring countries. Today, the country’s medical value travel (MVT) sector is a sophisticated ecosystem encompassing world-class hospital chains (Apollo, Fortis, Max, Medanta, Aster DM), JCI- and NABH-accredited facilities, specialised centres of excellence in oncology, cardiac surgery, transplant medicine and robotic surgery, and a growing integration of traditional AYUSH therapies with modern medical care.

The e-Medical Visa programme now covers 167 countries, with processing times significantly reduced. The “Heal in India” initiative, launched by the Ministry of Tourism, provides a dedicated portal for international patients to discover accredited facilities, compare treatments and plan their healthcare journey. The market is projected to grow at a 12.3% CAGR from 2026 to 2036, potentially reaching $65 billion, driven by rising inflows from Africa, the Middle East and Southeast Asia, expanding private hospital capacity and increasing preference for bundled care pathways.

Why Patients Choose India

• Cost advantage. Bypass grafts starting at $5,000 compared to $100,000 in the United States. Knee replacements at $6,000-8,000 versus $35,000-50,000. IVF treatments at $2,500-4,000 versus $12,000-15,000. Lower labour costs, high generic drug penetration and dense patient throughput sustain the pricing edge without compromising quality.
• Clinical capability. India has over 40 JCI-accredited hospitals and thousands of NABH-accredited facilities. Hospitals routinely perform complex procedures including proton therapy, CAR-T cell therapy, da Vinci robotic surgery, liver and kidney transplants and advanced cardiac interventions. Many lead clinicians have trained at top US and UK institutions.
• No waiting times. Unlike the NHS (UK) or public healthcare systems in Canada and Australia where patients wait months or years for elective procedures, Indian hospitals offer near-immediate scheduling. This is a decisive factor for patients with time-sensitive conditions.
• Wellness integration. India’s unique position as the birthplace of Ayurveda, yoga and naturopathy allows hospitals to offer integrated wellness and recovery programmes that combine modern medicine with traditional therapies. This is a growing differentiator, particularly for wellness tourism and post-treatment recovery.
• Language and communication. India’s English-speaking medical workforce and multilingual patient facilitation services (Arabic, Russian, French, Swahili) reduce communication barriers that patients face in other medical tourism destinations.

Source Markets and Patient Profiles

India’s medical tourist profile has diversified significantly:

• South Asia (Bangladesh, Nepal, Sri Lanka, Maldives). The largest source region by volume, driven by proximity, limited domestic specialist capacity and existing cultural and travel connections. Aster DM Healthcare reported 51% MVT revenue growth in Kerala driven by Maldivian and South Asian patients.
• Middle East and North Africa. Historically a major source market, particularly for cardiac, orthopaedic and oncology treatment. The West Asia conflict has caused temporary disruptions in 2025-26, but hospital chains have diversified into alternative regions.
• Africa. The fastest-growing source region, with patients from Nigeria, Kenya, Ethiopia, Tanzania and East Africa seeking treatments unavailable domestically. India’s cultural connections, direct flight routes and affordable pricing make it the preferred destination.
• Central Asia and CIS. Uzbekistan, Kazakhstan and other Central Asian countries are emerging sources, with patients seeking cardiac surgery, orthopaedics and fertility treatments.
• OECD countries. A smaller but growing segment, driven primarily by diaspora patients returning for elective procedures, dental care and wellness treatments, and by patients from countries with long NHS-style waiting times.

Government Policy and Infrastructure

• Five regional medical hubs. Budget 2026-27 proposed five medical hubs integrating medical services, education, research and wellness. Each hub will include dedicated AYUSH centres and MVT facilitation centres for international patients.
• e-Medical Visa. The simplified e-Medical Visa covers 167 countries, with multiple-entry provisions and companion visas for accompanying family members.
• Heal in India portal. The dedicated government portal provides international patients with information on accredited hospitals, treatment options, cost comparisons and travel logistics.
• International insurance tie-ups. Overseas insurance agreements with Maldives, Oman and Mauritius reduce out-of-pocket costs for patients, de-risking the financial decision.
• AYUSH promotion. The Ministry of AYUSH is actively promoting India as a wellness tourism destination, with dedicated yoga and Ayurveda tourism circuits.

Opportunities for Foreign Organisations

• Insurance companies. Foreign health insurers can develop India-inclusive treatment networks, offering policyholders access to high-quality, lower-cost procedures. Cross-border insurance products covering medical travel to India are an emerging category.
• National tourism boards. Countries with large outbound medical travel flows (particularly in the Middle East and Africa) can partner with Indian hospital chains to create structured referral pathways and patient facilitation programmes.
• Healthcare companies. Medical device manufacturers, pharmaceutical companies and health technology firms can leverage India’s medical tourism ecosystem as a distribution and demonstration channel for their products.
• Hospital management companies. Foreign hospital operators can explore JV or management contract arrangements with Indian hospital chains to build capacity in underserved specialties or geographies.
• Digital health platforms. AI-powered patient triage, teleconsultation, treatment matching and post-treatment monitoring platforms have significant opportunity in the Indian MVT market.

How T&A Consulting Supports Medical Tourism Strategy

T&A Consulting helps foreign organisations navigate India’s medical value travel ecosystem:

• Market research and demand analysis. We analyse source market demand, patient profiles, treatment preferences and competitive positioning for hospitals and healthcare organisations.
• Partnership facilitation. We identify and introduce foreign insurers, tourism boards and healthcare companies to Indian hospital chains, wellness centres and facilitation platforms.
• Policy advisory. We advise governments on medical visa policies, accreditation frameworks and medical tourism promotion strategies, drawing on India’s experience as a leading MVT destination.
• Investment advisory. We support foreign healthcare investors evaluating hospital assets, medical technology companies and digital health platforms in India.
• Marketing strategy. We design medical tourism marketing campaigns targeting specific source markets, incorporating digital outreach, trade engagement and medical conference participation.

Contact us at: pnijhawan@taglobalgroup.com to explore medical tourism opportunities in India.

Sources & references:
Mordor Intelligence, Future Market Insights, Outlook India, Travel and Tour World, ORF